| Market Capitalization (Millions $) |
156 |
| Shares
Outstanding (Millions) |
20 |
| Employees |
13 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-42 |
| Cash Flow (TTM) (Millions $) |
-15 |
| Capital Exp. (TTM) (Millions $) |
0 |
Inmune Bio Inc
Inmune Bio Inc. is a biotechnology company that focuses on developing novel immunotherapies to treat various types of diseases, particularly cancer and neurodegenerative disorders. The company utilizes its expertise in the field of immunology to develop innovative therapies that harness the power of the immune system. These therapies aim to stimulate the body's natural defense mechanisms to fight off diseases more effectively.
The company's approach involves the development of immunotherapies that target specific proteins or pathways involved in disease progression. Inmune Bio conducts extensive research and preclinical studies to identify potential targets and develop candidate drugs. They use a combination of cutting-edge technologies and biological platforms to design and optimize these therapies.
One of the key focuses of Inmune Bio is developing immunotherapies that target the tumor microenvironment. Their therapies aim to modulate the immune response in a way that enhances the body's ability to recognize and eliminate cancer cells. By manipulating the immune system, the company's therapies seek to improve patient outcomes and potentially reduce the need for traditional treatments such as chemotherapy or radiation.
In addition to cancer treatments, Inmune Bio is also involved in developing therapies for neurodegenerative disorders such as Alzheimer's disease. Their approach involves targeting specific proteins implicated in the progression of these disorders, with the goal of slowing down or halting disease progression.
Overall, Inmune Bio Inc. is dedicated to advancing the field of immunotherapy by developing innovative and effective treatments for cancer and neurodegenerative disorders. Through their research and development efforts, they aim to improve patient outcomes and provide new options for those suffering from these diseases.
Company Address: 225 NE Mizner Blvd Boca Raton 33432 FL
Company Phone Number: 964-3720 Stock Exchange / Ticker: NASDAQ INMB
|
0.26%